Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges

Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges

Ovarian cancer remains the leading cause of death from gynecological cancer. Survival is significantly related to the stage of the disease at diagnosis. Of quite importance is primary cytoreductive surgery, having as a goal to remove all visible tumor tissue, and is the standard primary treatment in...

Full description

Bibliographic Details
Main Authors: Adamantia Nikolaidi, Elena Fountzilas, Florentia Fostira, Amanda Psyrri, Helen Gogas, Christos Papadimitriou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
ovarian cancer
NACT
bevacizumab
PARPi
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.820128/full

Similar Items

Similar Items